Carlo Briguori, Davide Capodanno, Marco Contarini, Michael E Donahue, Salvatore Evola, Nadia Garro, Francesco Greco, Alessio LA Manna, Paola Murè, Antonino Nicosia, Giuseppe Migliore, Giorgio Sacchetta, Nicola Signore, Corrado Tamburino, Giampiero Vizzari, Giuseppe Biondi-Zoccai
BACKGROUND: Percutaneous coronary intervention (PCI) for bifurcation lesions still represents a clinical challenge. The Bioss Lim C is a dedicated device for bifurcation lesions, features a tapered shape and large cells, and thus appears as a promising adjunct to the current interventional cardiologists' armamentarium. We aimed at conducting a prospective multicenter study focusing on early and long-term results after Bioss Lim C implantation for true coronary bifurcation lesions. METHODS: Patients with true bifurcation lesions in whom Bioss Lim C implantation was attempted were enrolled in four Italian centers...
March 26, 2024: Minerva Medica